ARTICLE | Company News
Canada approves Baxter's NeisVac-C
January 14, 2002 8:00 AM UTC
Canada granted marketing approval to BAX for its NeisVac-C meningococcal group C vaccine. BAX acquired the product through its 1999 purchase of North American Vaccine, and Shire (LSE:SHP; SHPGY) has e...